India, Sept. 26 -- Although the tariff currently targets only branded drugs, it signals a broader shift toward protectionist trade policies that could have far-reaching implications

U.S. President Donald Trump has announced a sweeping 100% tariff on imported branded and patented pharmaceutical drugs-unless the producing companies have active manufacturing facilities within the United States. The measure, aimed at boosting domestic production and reducing dependency on foreign imports, will take effect fromOctober 1, 2025.

"Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. 'IS BUILDING' will be ...